{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T07:31:53Z","timestamp":1772177513539,"version":"3.50.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to evaluate the clinical value of repeat fine-needle aspiration biopsy (rFNAB) for thyroid nodules initially classified as Bethesda Category III, to explore the optimal timing for repeat biopsy, and to optimize the biopsy strategy by integrating ultrasonographic characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed the clinical data of 109 patients (114 nodules) who underwent rFNAB at our hospital from December 2020 to December 2025, including 87 females and 22 males. Based on rFNAB results, the nodules were divided into a definitive diagnosis group (93 nodules) and a non-definitive diagnosis group (21 nodules). The definitive diagnosis group was further subdivided into a malignant group (62 nodules, Bethesda V\/VI) and a benign group (31 nodules, Bethesda II). We recorded biopsy results, intervals between biopsies, postoperative pathological findings, and ultrasonographic features. Statistical differences between groups were analyzed. Statistical methods included the \u03c7\u00b2 test, Fisher\u2019s exact test, binary logistic regression analysis, and ROC curve analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 114 Bethesda Category III nodules, 93 (81.6%) obtained a definitive diagnosis through rFNAB, including 62 malignant (66.7%) and 31 benign (33.3%) nodules; 21 nodules (18.4%) remained non-diagnostic. Forty-seven patients with malignant rFNAB results underwent surgical treatment, including 9 (19.1%) in the &amp;lt;3-month interval group and 38 (80.9%) in the \u22653-month interval group. No significant differences were observed in lymph node metastasis rates or recurrence risk stratification between the two groups. Among the ultrasonographic characteristics of the malignant, benign, and non-diagnostic groups, only calcification type showed a statistically significant difference (P &amp;lt; 0.05). Additionally, ROC curve analysis confirmed the diagnostic efficacy of the TI-RADS score for Bethesda Category III nodules (AUC = 0.746). The maximum Youden index (0.403) was achieved at a cut-off value of 8 points (specificity 83.9%, sensitivity 56.5%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Repeat fine-needle aspiration biopsy (rFNAB) significantly improves the diagnostic rate for thyroid nodules initially diagnosed as Bethesda Category III, and the time interval between the two biopsies does not affect diagnostic performance. For the follow-up of nodules with an initial Bethesda Category III FNAB result, rFNAB is recommended when the TI-RADS score is \u22658, especially if suspicious ultrasonographic signs such as new or persistent microcalcifications are present. During the procedure, multi-point sampling should target non-calcified areas at the nodule periphery to improve the accuracy and reliability of rFNAB.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1750620","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:25:16Z","timestamp":1772169916000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The clinical value of repeat ultrasound-guided fine-needle aspiration biopsy in the management of Bethesda Category III thyroid nodules"],"prefix":"10.3389","volume":"17","author":[{"given":"Chong","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingfeng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rundong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa322","article-title":"Contemporary thyroid nodule evaluation and management","volume":"105","author":"Grani","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","first-page":"24216","DOI":"10.1038\/s41598-024-75677-7","article-title":"Diagnostic sensitivity of fine-needle aspiration cytology in thyroid cancer","volume":"14","author":"Lind","year":"2024","journal-title":"Sci Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60050722","article-title":"Diagnostic accuracy of ultrasound and fine-needle aspiration cytology in thyroid Malignancy","volume":"60","author":"Boudina","year":"2024","journal-title":"Med (Kaunas)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2023.0141","article-title":"The 2023 bethesda system for reporting thyroid cytopathology","volume":"33","author":"Ali","year":"2023","journal-title":"Thyroid"},{"key":"B5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1530\/EJE-21-0330","article-title":"Outcomes of repeat fineneedle aspiration biopsy for AUS\/FLUS thyroid nodules","volume":"185","author":"Bayona","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/jcu.23119","article-title":"The diagnostic value of second ultrasound-guided fine-needle aspiration for thyroid nodules","volume":"50","author":"Zhao","year":"2022","journal-title":"J Clin Ultrasound"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.13929\/j.issn.1003-3289.2021.09.008","article-title":"Repeat ultrasound-guided fine-needle aspiration biopsy for diagnosing Bethesda category I\/III thyroid nodules","volume":"37","author":"Yu","year":"2021","journal-title":"Chin J Med Imaging Technol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40463-019-0338-7","article-title":"The role of repeat fine needle aspiration in managing indeterminate thyroid nodules","volume":"48","author":"Allen","year":"2019","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21220","article-title":"Potential pitfalls of needle tract effects on repeat thyroid fine-needle aspiration","volume":"121","author":"Recavarren","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2022.03.002","article-title":"Fine-needle aspiration cytology repetition in thyroid nodules with non-diagnostic findings or atypia of undetermined significance\/follicular lesions of undetermined significance: Does time matters","volume":"83","author":"Benido Silva","year":"2022","journal-title":"Ann Endocrinol (Paris)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.endien.2024.03.018","article-title":"Repetition of thyroid fine-needle aspiration cytology after an initial nondiagnostic result: Is there an optimal timing","volume":"71","author":"Cosme","year":"2024","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1007\/s12020-024-03999-7","article-title":"Correction: Timing of the repeat thyroid fine-needle aspiration biopsy: does early repeat biopsy change the rate of nondiagnostic or atypia of undetermined significance cytology result","volume":"86","author":"Dellal Kahramanca","year":"2024","journal-title":"Endocrine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12902-020-0530-9","article-title":"Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology","volume":"20","author":"Yaprak Bayrak","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-016-4311-9","article-title":"Repeat fine-needle aspiration can be performed at 6 months or more after initial atypia of undetermined significance or follicular lesion of undetermined significance results for thyroid nodules 10 mm or larger","volume":"26","author":"Koh","year":"2016","journal-title":"Eur Radiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.surg.2019.03.040","article-title":"Active surveillance of low-risk papillary thyroid cancer: A meta-analysis","volume":"167","author":"Saravana-Bawan","year":"2020","journal-title":"Surgery"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e17924","DOI":"10.7759\/cureus.17924","article-title":"The prediction of Malignancy risk in thyroid nodules classified as bethesda system category III (AUS\/FLUS) and the role of ultrasound finding for prediction of Malignancy risk","volume":"13","author":"Alshahrani","year":"2021","journal-title":"Cureus"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e18780","DOI":"10.1097\/MD.0000000000018780","article-title":"Malignancy rate of Bethesda category III thyroid nodules according to ultrasound risk stratification system and cytological subtype","volume":"99","author":"Yoo","year":"2020","journal-title":"Med (Baltimore)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"20420188221122486","DOI":"10.1177\/20420188221122486","article-title":"The prevalence and associated predictors for Bethesda III-VI for reporting thyroid cytopathology in Royal Commission Hospital, Kingdom of Saudi Arabia","volume":"13","author":"Alyousif","year":"2022","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14184489","article-title":"Optimization of the management of category III thyroid nodules using repeat FNA and TIRADS","volume":"14","author":"S\u0142owi\u0144ska-Klencka","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2021.0119","article-title":"Do ultrasound patterns and clinical parameters inform the probability of thyroid cancer predicted by molecular testing in nodules with indeterminate cytology","volume":"31","author":"Figge","year":"2021","journal-title":"Thyroid"},{"key":"B21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.12998\/wjcc.v4.i2.38","article-title":"Cytopathologic diagnosis of fine needle aspiration biopsies of thyroid nodules","volume":"4","author":"Misiakos","year":"2016","journal-title":"World J Clin Cases"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.3389\/fsurg.2022.907086","article-title":"Analysis of factors influencing the satisfaction rate of fine-needle aspiration biopsy specimens from thyroid nodules","volume":"23","author":"Zheng","year":"2021","journal-title":"Chin J Physicians"},{"key":"B23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.13929\/j.issn.1672-8475.2022.08.004","article-title":"Factors influencing the quality of ultrasound-guided fine-needle aspiration specimens of thyroid nodules","author":"Chen","year":"2022","journal-title":"Chin J Interventional Imaging Ther"},{"key":"B24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/cncy.20178","article-title":"The atypical thyroid fine-needle aspiration: past, present, and future","volume":"120","author":"Bongiovanni","year":"2012","journal-title":"Cancer Cytopathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.19538\/j.cjps.issn1005-2208.2025.01.05","article-title":"Chinese expert consensus and operative guidelines on ultrasound-guided fine-needle aspiration biopsy for thyroid nodules and cervical lymph nodes (2025 Edition)","volume":"45","author":"Tian","year":"2025","journal-title":"Chin J Pract Surg"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21879","article-title":"The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on the performance of the Afirma gene expression classifier","volume":"125","author":"Hang","year":"2017","journal-title":"Cancer Cytopathol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1155","article-title":"A 2015 survey of clinical practice patterns in the management of thyroid nodules","volume":"101","author":"Burch","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1530\/EJE-21-1293","article-title":"DIAGNOSIS OF ENDOCRINE DISEASE: Usefulness of genetic testing of fine-needle aspirations for diagnosis of thyroid cancer","volume":"187","author":"Stewardson","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0779","article-title":"Molecular testing versus diagnostic lobectomy in bethesda III\/IV thyroid nodules: A cost-effectiveness analysis","volume":"29","author":"Nicholson","year":"2019","journal-title":"Thyroid"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1750620\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:25:18Z","timestamp":1772169918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1750620\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":29,"alternative-id":["10.3389\/fendo.2026.1750620"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1750620","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"article-number":"1750620"}}